PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

ATS Corporation_November_2022_288_89288 - ATS Corporation | Presentation Nation

HomepageATS CorporationATS Corporation_November_2022_288_89288

ATS Corporation_November_2022_288_89288

ATS Corporation

Browse presentations, reports, and documents from ATS Corporation.

Tags

2022

Filter options

All (13)●
earnings (1)○
investor_presentation (3)○
presentation (9)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

ATS Corporation_November_2022_288_89288 by ATS Corporation.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from ATS Corporation

ats-agm-presentation-fy23_v5

presentation

ATS Corporation_August_2021_576_73576

presentation

Similar presentations from other companies

Canada-Silver-Corporate-Presentation-April-4-2022_compressed

presentation

Canada Silver Cobalt Works

June%202021%20Investor%20Presentation%20-%20Final

presentation

Covanta Holding Corporation

ATS Corporation_August_2021_643_73643

presentation

ATS Corporation_August_2022_421_86421

presentation

ATS Corporation Avidity Science Acquisition 2023

investor_presentation

investor_presentation

15 Pages

ATS Corporation_February_2021_104_65104

presentation

20211021-Barclays-PLC-Q321-FI-Results-Presentation

presentation

Barclays

Erytech Pharma_May_2022_543_83543

presentation

Erytech Pharma

Cabot Corporation_May_2018_370_28370

presentation

Cabot Corporation

Mirum Pharmaceuticals_May_2022_821_82821

presentation

Mirum Pharmaceuticals